Abstract
We report on a Japanese girl with short stature, malar hypoplasia, up-slanting palpebral fissures, blue sclerae and thin, stiff and slightly brownish hair. Short stature started in utero and her psychomotor development was normal. Menarche appeared at 13 years 8 months. Height at 14 years 5 months was 132 cm (−4.6 SD). Her growth hormone (GH) sleep pattern and responses to insulin,l-dopa, arginine, propranolol-glucagon and growth hormone-releasing hormone were normal. Plasma insulin-like growth factor I (IGF-I) was high (2170–4860 units/l) and increased from 4860 to 7080 units/l 20 h after biosynthetic GH injection. Gel infiltration patterns of the free and protein-bound IGF-I in plasma from the patient were not different from the controls; IGF-I fraction of the high and low molecular weight binding protein and the non-protein bound fraction were 75.5%, 15.8% and 8.7%, respectively. IGF-I from the patient showed normal bioactivities when determined by [35S]sulphate and [3H]thymidine uptake into cultured rat chondrocytes, and by [3H]thymidine and [3H]α-aminoisobutyric acid uptake into the patient's skin fibroblasts. IGF-I binding to cultured skin fibroblasts from the patient was comparable to that of controls. These results suggest that tissue specific defects of IGF-I receptors may be the cause of increased IGF-I levels in the patient.
Similar content being viewed by others
Abbreviations
- AIB:
-
α-aminoisobutyric acid
- DMEM:
-
Dulbecco's minimum essential medium
- GH:
-
growth hormone
- IGF-I:
-
insulin-like growth factor I
References
Baumann G, Shaw MA, Merimee TJ (1989) Low levels of high-affinity growth hormone-binding protein in African Pygmies. N Engl J Med 320:1705–1709
Bierich JR, Moeller H, Ranke MB, Rosenfeld RG (1984) Pseudopituitary dwarfism due to resistance to somatomedin: a new syndrome. Eur J Pediatr 142:186–188
Carmina E, Lo Coco R, Porcelli P, Lanzara P, Janni A (1980) Dwarfism with high somatomedin activity and delayed bone age: a syndrome of receptor insensitivity to the somatomedins? In: La Cauza C, Root AW (eds) Problems in pediatric endocrinology. Academic Press, New York, pp 147–151
Chatelain PG, Van Wyk JJ, Copeland KC, Blethen SL, Underwood LE (1983) Effect of in vitro action of serum proteases or exposure to acid on measurable immunoreactive somatomedin-C in serum. J Clin Endocrinol Metab 56:376–383
Flier JS, Usher P, Moses AC (1986) Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor mediated DNA synthesis: Clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci USA 83:664–668
Freychet P, Kahn CR, Roth J, Neville DM (1972) Insulin interactions with liver plasma membranes: independence of binding of the hormone and its degradation. J Biol Chem 247:3953–3961
Gruelich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist. Stanford University Press, Stanford
Heath-Monning E, Wohltmann HJ, Mills-Dunlap B, Daughaday WH (1987) Measurement of insulin-like growth factor I (IGF-I) responsiveness of fibroblasts of children with short stature: identification of a patient with IGF-I resistance. J Clin Endocrinol Metab 64:501–507
Hinegardner RT (1971) An improved fluorometric assay for DNA. Anal Biochem 39:197–201
Hizuka N, Takano K, Shizume K, Fukuyama Y (1984) Measurement of plasma somatomedin-C levels by somatomedin-C RIA kit. (in Japanese) Clin Endocrinol (Tokyo) 32:463–466
Kato Y, Nomura Y, Daikuhara Y, Nasu N, Tsuji M, Asada A, Suzuki F (1980) Cartilage-derived factor (CDF). I. Stimulation of proteoglycan synthesis in rat and rabbit costal chondrocytes in culture. Exp Cell Res 130:73–81
Knight AB, Rechler MM, Romanus JA, Van Obberghen-Schilling EE, Nissley SP (1981) Stimulation of glucose incorporation and amino acid transport by insulin and an insulin-like growth factor in fibroblasts with defective insulin receptors cultured from a patient with leprechaunism. Proc Natl Acad Sci USA 78:2554–2558
Kowarski AA, Schneider J, Ben-Galim E, Weldon VV, Daughaday WH (1978) Growth failure with normal serum RIA-GH and low somatomedin activity: Somatomedin restoration and growth acceleration after exogenous GH. J Clin Endocrinol Metab 47:461–464
Lanes R, Plotnick LP, Spencer EM, Daughaday WH, Kowarski AA (1980) Dwarfism associated with normal serum growth hormone and increased bioassayable, receptorassayable, and immunoassayable somatomedin. J Clin Endocrinol Metab 50:485–488
Laron A, Pertzelan A, Mannheimer S (1966) Genetic pituitary dwarfism with high serum concentration of growth hormone. A new inborn error of metabolism? Isr J Med Sci 2:152–155
Niwa M, Sato S, Saito Y, Uchiyama F, Ono H, Yamashita M, Kitaguchi T, Shiga Y, Notani J, Yamada H, Ishii Y, Ueda I, Takagi Y (1986) Chemical synthesis, cloning, and expression of genes for human somatomedin C (insulin-like growth factor I) and59Val-somatomedin C. Ann NY Acad Sci 469:31–52
Pintor C, Loche S, Cella SG, Muller EE, Baumann G (1989) A child with phenotypic Laron dwarfism and normal somatomedin levels. N Engl J Med 320:376–379
Sasaoka T, Kobayashi M, Takata Y, Ishibashi O, Iwasaki M, Shigeta Y, Goji K, Hisatomi A (1988) Clarification of signaling pathways mediated by insulin and insulin-like growth factor I receptors in fibroblasts from patients with specific defect in insulin receptor. Diabetes 37:1515–1523
Shimomura Y, Yoneda T, Suzuki F (1975) Osteogenesis by chondrocytes from growth cartilage of rat rib. Calcif Tissue Res 19:179–187
Suwa S, Katsumata N, Maesaka H, Tokuhiro E, Yokoya S (1988) Serum insulin-like growth factor I (somatomedin-C) level in normal subjects from infancy to adulthood, pituitary dwarfs and normal variant short children. Endocrinol Jap 35:857–864
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Momoi, T., Yamanaka, C., Kobayashi, M. et al. Short stature with normal growth hormone and elevated IGF-I. Eur J Pediatr 151, 321–325 (1992). https://doi.org/10.1007/BF02113248
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02113248